Last reviewed · How we verify
Cholecystitis
Approved treatments
- Doribax · Shionogi
- Zerbaxa · Cubist Pharms
Zerbaxa works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Zosyn · Merck Sharp & Dohme B.V.
Zosyn works by blocking bacterial enzymes that break down antibiotics, allowing the antibiotics to kill bacteria more effectively.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Cholecystitis patent landscape — cliff calendar, originator estates, attackable patents
- Cholecystitis treatment landscape brief
- Cholecystitis treatment updates RSS
Frequently asked questions about Cholecystitis
What drugs treat Cholecystitis?
Tracked treatments include Doribax, Zerbaxa, Zosyn.
What is the treatment for Cholecystitis?
Standard treatment for Cholecystitis includes Doribax, Zerbaxa, Zosyn. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Cholecystitis patent cliff · Cholecystitis CI report
- Treatment: Doribax · Shionogi
- Treatment: Zerbaxa · Cubist Pharms
- Treatment: Zosyn · Merck Sharp & Dohme B.V.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing